Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The oculomotor nerve (cranial nerve III) is a complex anatomical structure originating from the midbrain that serves both somatic motor and autonomic functions for the eye. It provides motor innervation to the superior, medial, and inferior recti, the inferior oblique muscle, and the levator palpebrae superioris, which are essential for coordinated eye movement and eyelid elevation [StatPearls, NBK541103]. Additionally, it carries parasympathetic fibers from the Edinger-Westphal nucleus that synapse in the ciliary ganglion to regulate the pupillary sphincter and ciliary muscles, controlling light entry and lens accommodation [NIH, NBK537159]. While not a molecular target itself, the nerve's signaling pathways—specifically the cholinergic transmission at the neuromuscular junction and post-ganglionic parasympathetic synapses—are the sites of action for various drugs such as botulinum toxin and muscarinic agents. Pathological involvement of the nerve is a critical clinical finding in conditions ranging from diabetic mononeuropathy to life-threatening aneurysms, typically manifesting as diplopia, ptosis, and pupillary dilation.
Pharmacological agents interact with the oculomotor nerve pathway primarily by modulating cholinergic transmission. This includes inhibiting acetylcholine release at the neuromuscular junction (e.g., Botulinum toxin) or acting as agonists/antagonists at nicotinic receptors on the extraocular muscles and muscarinic receptors on the pupillary sphincter and ciliary body [StatPearls, NBK541103].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oculomotor nerve (CN III).